Autonomix Medical, Common Stock Investor Sentiment

AMIX Stock   3.35  0.18  5.10%   
Slightly above 64% of Autonomix Medical,'s investor base is looking to short. The analysis of overall sentiment of trading Autonomix Medical, Common stock suggests that many investors are alarmed at this time. Autonomix Medical,'s investing sentiment can be driven by a variety of factors including economic data, Autonomix Medical,'s earnings reports, geopolitical events, and overall market trends.
  
over six months ago at globenewswire.com         
Autonomix to Present at the Benzinga Virtual Healthcare Summit 2024
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
Autonomix to Present at the Benzinga Virtual Healthcare Summit 2024
Yahoo News
over six months ago at investing.com         
Autonomix Medical hires new Chief Business Officer
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
Autonomix Appoints Jennifer Cook as Chief Business Officer
Yahoo News
over six months ago at globenewswire.com         
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-D...
Macroaxis News: globenewswire.com
over six months ago at thelincolnianonline.com         
Autonomix Medical, Inc.s Quiet Period To Expire on March 11th
news
over six months ago at finance.yahoo.com         
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic C...
Yahoo News
over six months ago at finance.yahoo.com         
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial
Yahoo News
over six months ago at www.macroaxis.com         
Autonomix Medical exotic insider transaction detected
Macroaxis News
over six months ago at finance.yahoo.com         
Autonomix Medical, Inc. to Participate in the Virtual Investor Lunch Break The Autonomix Opportunity
Yahoo News
over six months ago at globenewswire.com         
Autonomix Medical, Inc. to Participate in the Virtual Investor Lunch Break The Autonomix Opportunity
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
Yahoo News
over six months ago at marketwatch.com         
Autonomix Medical Shares Rise 13 percent After Site Initiation for Clinical Study
marketwatch News
over six months ago at investing.com         
Autonomix advances pancreatic cancer pain treatment study
Investing News at Macroaxis
over six months ago at globenewswire.com         
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Autonomix Medical, that are available to investors today. That information is available publicly through Autonomix media outlets and privately through word of mouth or via Autonomix internal channels. However, regardless of the origin, that massive amount of Autonomix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Autonomix Medical, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Autonomix Medical, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Autonomix Medical,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Autonomix Medical, alpha.

Autonomix Medical, Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Smith Trent N. of Autonomix Medical, subject to Rule 16b-3
09/18/2024
2
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
09/26/2024
3
Autonomix Announces Reverse Stock Split
10/22/2024
4
Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th
10/25/2024
5
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday
10/28/2024
6
Autonomix Medical, Inc. Announces Pricing of 9.0 Million Underwritten Public Offering
11/22/2024
7
Autonomix Medical, Inc. Announces Closing of 10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
11/25/2024
8
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful ...
12/05/2024

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.